Mortgage Advice Bureau has confirmed Jo Stent as group chief financial officer and an executive director of the AIM-quoted intermediary, completing a succession that the company set in motion in the summer.
Stent took up the role at the start of October. She had been chief financial officer designate since early July, an arrangement that gave her close to three months inside the business before assuming the statutory responsibilities. The outgoing finance chief, Emilie McCarthy, departed the previous day.
The announcement also disclosed the resignation of a non-executive director, Nathan Imlach, which means the board is carrying two changes rather than one. Companies generally prefer to separate those events, and the decision to disclose them together suggests the non-executive departure was timed to the board cycle rather than to the finance transition.
An unusually varied finance career
Stent qualified as a chartered accountant at Ernst and Young and has since held finance leadership roles across a wider range of sectors than is typical for a listed company finance chief. She was chief financial officer of Frontier IP Group, the intellectual property commercialisation business, from April 2024 until May 2026, and before that chief financial officer of Argentex Group, the foreign exchange services firm, from February 2021.
Further back she was finance chief of the European Tour and Ryder Cup Europe, and before that held senior finance positions at Vodafone Americas, at Telus and at Deloitte. The common thread is businesses whose revenue is transactional and cyclical rather than contracted, which is a reasonable description of mortgage intermediation.
The cycle she joins
Mortgage Advice Bureau earns its revenue from the volume of mortgage completions its adviser network produces, which makes it a geared play on UK housing transaction activity rather than on house prices. That exposure has been uncomfortable through a period of elevated rates, in which transaction volumes fell well below the long-run average and adviser productivity came under pressure across the sector.
The finance question for the company is accordingly about operating leverage. The adviser network is largely a fixed cost base in the short term, so a recovery in transaction volumes flows to margin quickly, and a further decline does the reverse. Managing that, and the dividend expectations of an AIM shareholder register accustomed to distributions, is the central part of the role.
Governance detail
The company disclosed Stent's previous directorships as part of the appointment, including the Frontier IP and Argentex positions, which is the standard AIM requirement for an incoming director. No other matters requiring disclosure were reported.
The handover from a designate period into the permanent role, with the predecessor leaving the day before, is the orderly pattern boards prefer and indicates the transition was planned rather than forced.
